左卡尼汀联合氟尿嘧啶对MGC803细胞增殖及凋亡影响的研究

郎娟娟, 钱兴运, 陶若琳, 刘艳霞, 王晨

中国药学杂志 ›› 2016, Vol. 51 ›› Issue (24) : 2102-2108.

PDF(1471 KB)
PDF(1471 KB)
中国药学杂志 ›› 2016, Vol. 51 ›› Issue (24) : 2102-2108. DOI: 10.11669/cpj.2016.24.005
消化道肿瘤药物的研发与临床应用专栏

左卡尼汀联合氟尿嘧啶对MGC803细胞增殖及凋亡影响的研究

  • 郎娟娟1,2, 钱兴运1, 陶若琳1, 刘艳霞2, 王晨1*
作者信息 +

Effects of Combination Treatment with L-Carnitine and 5-Fluorouracil on Proliferation and Apoptosis in MGC803 Cells

  • LANG Juan-juan1,2, QIAN Xing-yun1, TAO Ruo-lin1, LIU Yan-xia2, WANG Chen1*
Author information +
文章历史 +

摘要

目的 探讨左卡尼汀对氟尿嘧啶(5-fluorouracil,5-Fu)抑制人胃腺癌MGC803细胞增殖作用的影响。方法 将MGC803细胞分为阴性对照组、5-Fu组、左卡尼汀和5-Fu联合用药组(左卡尼汀+/→5-Fu)进行实验。四甲基偶氮唑蓝(MTT)法检测细胞的增殖,流式细胞术检测细胞凋亡和细胞周期,蛋白质印迹法检测Bcl-2、Bax、ANT1和cleaved-PARP蛋白的表达。结果 与5-Fu单药组相比,左卡尼汀和5-Fu联合用药组抑制MGC803细胞增殖的作用增强,细胞凋亡百分率增大,细胞周期S期阻滞,上调Bax、ANT1和cleaved-PARP蛋白的表达,下调Bcl-2蛋白的表达。实验结果还显示,左卡尼汀和5-Fu联合应用时,给药方法可以影响5-Fu对MGC803细胞的抑制作用。与左卡尼汀+5-Fu组相比,左卡尼汀→5-Fu组细胞凋亡百分率由(19.60±1.06)%增加至(24.17±3.12)%(P<0.05),G0/G1期细胞比例由(72.95±0.91)%降低至(62.62±1.04)%,S期细胞比例由(27.05±0.91)%增加至(37.35±1.03)%(P<0.001)。结论 左卡尼汀可能通过影响Bcl-2家族蛋白的表达和细胞周期,增强5-Fu对MGC803细胞增殖的抑制作用。

Abstract

OBJECTIVE To investigate the effects of combination treatment with L-carnitine and 5-fluorouracil on the proliferation and cell apoptosis of gastric cancer MGC803 cells. METHODS MGC803 cells were divided into control group, 5-fluorouracil group and the combination of L-carnitine and 5-fluorouracil group (L-carnitine+/→5-fluorouracil group) in vitro. The inhibitory rate of cells was measured by MTT assay. The apoptosis rate and cell cycle of cells were detected by FLOW. Western blot was used to analyzed the expression of Bcl-2, Bax, adenine nucleotide translocator1(ANT1) and cleaved-PARP. RESULTS Compared with 5-fluorouracil group, the inhibition rate of MGC803 cells was increased when cells were treated with the combination of L-carnitine and 5-fluorouracil. The apoptosis rate of cells was raised and the cells were blocked at S phase. In addition, the combination group can decrease the expression of Bcl-2 and increase the expression of Bax, ANT1 and cleaved-PARP. At the same time, the apoptosis rate of cells and the cell cycle were different with the different dosage regimen when treated with the combination. Compared with the L-carnitine+5-fluorouracil group, the apoptosis rate of cells was increased to (24.17±3.12)% from (19.60±1.06)% (P<0.05). The G0/G1 phase proportion of cells was decreased to (62.62±1.04)% from (72.95±0.91)%,and the S phase proportion of cells was increased to (37.35±1.03)% from (27.05±0.91)% (P<0.001). CONCLUSION Treatment with L-carnitine and 5-fluorouracil could enhance the inhibitory effect of 5-fluorouracil on MGC803 cells. The possible mechanism of action is achieved by regulating the expression of Bcl-2 protein family and influencing the cell cycle.

关键词

MGC803细胞 / 左卡尼汀 / 氟尿嘧啶 / 联合应用 / 给药方法 / 细胞凋亡

Key words

MGC803 cells / L-carnitine / 5-fluorouracil / combination treatment / dosage regimen / cell apoptosis

引用本文

导出引用
郎娟娟, 钱兴运, 陶若琳, 刘艳霞, 王晨. 左卡尼汀联合氟尿嘧啶对MGC803细胞增殖及凋亡影响的研究[J]. 中国药学杂志, 2016, 51(24): 2102-2108 https://doi.org/10.11669/cpj.2016.24.005
LANG Juan-juan, QIAN Xing-yun, TAO Ruo-lin, LIU Yan-xia, WANG Chen. Effects of Combination Treatment with L-Carnitine and 5-Fluorouracil on Proliferation and Apoptosis in MGC803 Cells[J]. Chinese Pharmaceutical Journal, 2016, 51(24): 2102-2108 https://doi.org/10.11669/cpj.2016.24.005
中图分类号: R965   

参考文献

[1] DENG J, LEI W, XIANG X J, et al. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway[J]. Oncotarget, 2016, 7(9):10037-10050.
[2] ZOU W B, LI Z S. Chinese gastric cancer incidence and mortality study progress[J]. Chin J Pract Int Med(中国实用内科杂志), 2014,34(4):408-415.
[3] MATSUSAKA S, LENZ H J. Pharmacogenomics of fluorouracil-based chemotherapy toxicity[J]. Expert Opin Drug Metab Toxicol, 2015, 11(5):811-821.
[4] WOUTERS K A, KREMER L C, MILLER T L, et al. Protecting against anthracycline-induced myocardial damage:a review of the most promising strategies[J]. Br J Haematol, 2005, 131(5):561-578.
[5] MINOTTI G, MENNA P, SALVATORELLI E, et al. Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J]. Pharmacol Rev, 2004, 56(2):185-229.
[6] SEYMOUR L, BRAMWELL V, MORAN L A. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group[J]. Cancer Prev Control, 1999, 3(2):145-159.
[7] EL-ASHMAWY N E, KHALIL R M. A review on the role of carnitine in the management of tamoxifen side effects in treated women with breast cancer[J]. Tumour Biol, 2014, 35(4):2845-2855.
[8] ALSHABANAH O A, HAFEZ M M, AL-HARBI M M, et al. Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation[J]. Oxid Med Cell Longev, 2010, 3(6):428-433.
[9] YE Y, WANG C, WANG D, et al. Effect of combination treatment with L-carnitine and epirubicin on proliferation and apoptosis in GLC-82 cell and its mechanism[J]. Chin J Cancer Prev Treat(中华肿瘤防治杂志), 2013, 20(10):744-748.
[10] SRINIVAS U S, DYCZKOWSKI J, BEISSBARTH T, et al. 5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair[J]. Oncotarget, 2015, 6(14):12574-12586.
[11] CASALS N, ZAMMIT V, HERRERO L, et al. Carnitine palmitoyltransferase 1C:from cognition to cancer[J]. Prog Lipid Res, 2016, 61(1):134-148.
[12] RIBAS G S, VARGAS C R, WAJNER M. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders[J]. Gene, 2014, 533(2):469-476.
[13] JIN Y Z, WANG G F, WANG Q, et al. Effects of acetaldehyde and L-carnitine on morphology and enzyme activity of myocardial mitochondria in rats[J]. Mol Biol Rep, 2014, 41(12):7923-7928.
[14] BI L, YAN X, CHEN W, et al. Antihepatocellular carcinoma potential of tetramethylpyrazine induces cell cycle modulation and mitochondrial-dependent apoptosis:regulation of p53 signaling pathway in HepG2 cells in vitro [J]. Integr Cancer Ther, 2016, 15(2):226-236.
[15] SONG R S, XIAO X H, LIU Z L, et al. Effects of a monomer purified from paris polyphylla(PP-22) on proliferation and apoptosis of human gastric carcinoma MGC803 cells[J]. Chin Pharm J(中国药学杂志), 2015, 50(18):1600-1606.
[16] BAINES C P, MOLKENTIN J D. Adenine nucleotide translocase-1 induces cardiomyocyte death through upregulation of the pro-apoptotic protein Bax[J]. J Mol Cell Cardiol, 2009, 46(6):969-977.
[17] JANG J Y, CHOI Y, JEON Y K, et al. Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo[J]. BMC Cancer, 2008, 8(4):160-169.
[18] RUGGIERI S, ORSOMANDO G, SORCI L, et al. Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues[J]. Biochim Biophys Acta, 2015, 1854(9):1138-1149.
[19] ZOVKO A, VIKTORSSON K, HAAG P, et al. Marine sponge Cribrochalina vasculum compounds activate intrinsic apoptotic signaling and inhibit growth factor signaling cascades in non-small cell lung carcinoma[J]. Mol Cancer Ther, 2014, 13(12):2941-2954.
[20] XAVIER PINTO M C, KIHARA A H, GOULART V A M, et al. Calcium signaling and cell proliferation[J]. Cell Signal, 2015, 27(11):2139-2149.

基金

天津市应用基础与前沿技术研究计划(一般项目)(14JCYBJC28600)
PDF(1471 KB)

80

Accesses

0

Citation

Detail

段落导航
相关文章

/